Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 3376 AL 3390

Placebo analgesia and nocebo hyperalgesia in patients with Alzheimer disease and healthy participants

Matthiesen ST, Sieg M, Andersen SS, Amanzio M, Finnerup NB, Jensen TS, Gottrup H, Vase L.

Pain. 2024 Feb 1;165(2):440-449. doi: 10.1097/j.pain.0000000000003035. Epub 2023 Sep 8.

Translational strategies and systems biology insights for blood-brain barrier opening and delivery in brain tumors and Alzheimer's disease

Song G, Plumlee P, Ahn JY, Wong ST, Zhao H.

Biomed Pharmacother. 2023 Nov;167:115450. doi: 10.1016/j.biopha.2023.115450. Epub 2023 Sep 11.

Alzheimer's disease as a viral disease: Revisiting the infectious hypothesis

Bruno F, Abondio P, Bruno R, Ceraudo L, Paparazzo E, Citrigno L, Luiselli D, Bruni AC, Passarino G, Colao R, Maletta R, Montesanto A.

Ageing Res Rev. 2023 Nov;91:102068. doi: 10.1016/j.arr.2023.102068. Epub 2023 Sep 12.

Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease

Bettinetti-Luque M, Trujillo-Estrada L, Garcia-Fuentes E, Andreo-Lopez J, Sanchez-Varo R, Garrido-Sánchez L, Gómez-Mediavilla Á, López MG, Garcia-Caballero M, Gutierrez A, Baglietto-Vargas D.

Br J Pharmacol. 2024 Mar;181(6):840-878. doi: 10.1111/bph.16243. Epub 2023 Oct 3.

Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease

Kron JOJ, Keenan RJ, Hoyer D, Jacobson LH.

Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:359-386. doi: 10.1146/annurev-pharmtox-040323-031929. Epub 2023 Sep 14.

The neuroinflammatory astrocytic P2X7 receptor: Alzheimer's disease, ischemic brain injury, and epileptic state

Ahn YH, Tang Y, Illes P.

Expert Opin Ther Targets. 2023 Jul-Dec;27(9):763-778. doi: 10.1080/14728222.2023.2258281. Epub 2023 Sep 15.

Comparative study of Raman spectroscopy techniques in blood plasma-based clinical diagnostics: A demonstration on Alzheimer's disease

Kralova K, Kral M, Vrtelka O, Setnicka V.

Spectrochim Acta A Mol Biomol Spectrosc. 2024 Jan 5;304:123392. doi: 10.1016/j.saa.2023.123392. Epub 2023 Sep 9.

Long-Term Safety, Tolerability, and Efficacy of a Transdermal Donepezil Patch in Patients with Severe Alzheimer's Disease

Nakamura Y, Narita K, Kim R, Nishiyama K, Kikuchi T, Ishikawa I, Aoki H.

J Alzheimers Dis. 2023;95(4):1535-1543. doi: 10.3233/JAD-230386.

mTOR signaling and Alzheimer's disease: What we know and where we are?

Davoody S, Asgari Taei A, Khodabakhsh P, Dargahi L.

CNS Neurosci Ther. 2024 Apr;30(4):e14463. doi: 10.1111/cns.14463. Epub 2023 Sep 18.

Glycogen Synthase Kinase-3β, NLRP3 Inflammasome, and Alzheimer's Disease

Jia YR, Guo ZQ, Guo Q, Wang XC.

Curr Med Sci. 2023 Oct;43(5):847-854. doi: 10.1007/s11596-023-2788-4. Epub 2023 Sep 18.

Targeting protein kinases for the treatment of Alzheimer's disease: Recent progress and future perspectives

Li Z, Yin B, Zhang S, Lan Z, Zhang L.

Eur J Med Chem. 2023 Dec 5;261:115817. doi: 10.1016/j.ejmech.2023.115817. Epub 2023 Sep 13.

Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab

VandeVrede L, La Joie R, Horiki S, Mundada NS, Koestler M, Hwang JH, Ljubenkov PA, Rojas JC, Rabinovici GD, Boxer AL, Seeley WW.

Acta Neuropathol. 2023 Nov;146(5):777-781. doi: 10.1007/s00401-023-02631-8. Epub 2023 Sep 19.

Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer's Disease: Recent Trends and Future Development

Dave BP, Shah YB, Maheshwari KG, Mansuri KA, Prajapati BS, Postwala HI, Chorawala MR.

Cell Mol Neurobiol. 2023 Nov;43(8):3847-3884. doi: 10.1007/s10571-023-01408-7. Epub 2023 Sep 19.

Stress granule-mediated RNA regulatory mechanism in Alzheimer's disease

Sato K, Takayama KI, Inoue S.

Geriatr Gerontol Int. 2024 Mar;24 Suppl 1:7-14. doi: 10.1111/ggi.14663. Epub 2023 Sep 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias